Rafferty Asset Management
STOK icon

Rafferty Asset Management’s Stoke Therapeutics STOK Stock Holding History

Rafferty Asset Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
43,742
-16,156
-27% -$518K ﹤0.01% 722
2026
Q1 		$1.95M Sell
59,898
-30,295
-34% -$994K 0.01% 619
2025
Q4 		$2.86M Buy
90,193
+54,866
+155% +$1.65M 0.01% 572
2025
Q3 		$830K Sell
35,327
-16,131
-31% -$276K ﹤0.01% 832
2025
Q2 		$584K Sell
51,458
-10,248
-17% -$97.3K ﹤0.01% 853
2025
Q1 		$410K Sell
61,706
-5,521
-8% -$51.5K ﹤0.01% 908
2024
Q4 		$742K Sell
67,227
-15,561
-19% -$191K ﹤0.01% 840
2024
Q3 		$1.02M Buy
82,788
+2,903
+4% +$41.1K ﹤0.01% 796
2024
Q2 		$1.08M Buy
+79,885
New +$1.08M ﹤0.01% 806
2023
Q1 		– Sell
-14,429
Closed -$133K – 1165
2022
Q4 		$133K Buy
14,429
+3,382
+31% +$35.2K ﹤0.01% 1099
2022
Q3 		$142K Buy
+11,047
New +$176K ﹤0.01% 1110
2022
Q2 		– Sell
-62,065
Closed -$1.31M – 1219
2022
Q1 		$1.31M Buy
62,065
+15,624
+34% +$313K 0.01% 727
2021
Q4 		$1.11M Buy
46,441
+13,926
+43% +$332K 0.01% 821
2021
Q3 		$827K Sell
32,515
-278
-0.8% -$7.75K 0.01% 913
2021
Q2 		$1.1M Sell
32,793
-2,027
-6% -$71.7K 0.01% 847
2021
Q1 		$1.35M Buy
+34,820
New +$1.98M 0.01% 703

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rafferty Asset Management's STOK Position: Q2 2026 in Review

Rafferty Asset Management reduced its Stoke Therapeutics (STOK) stake by 27% in Q2 2026, selling an estimated $518K and leaving 43,742 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #722.

Rafferty Asset Management first reported a position in STOK in Q1 2021 and has held it in 16 quarters since. The position peaked at $2.86M in Q4 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Rafferty Asset Management held 43,742 shares of Stoke Therapeutics worth $1.43M as of Q2 2026.
  • Rafferty Asset Management sold 16,156 Stoke Therapeutics shares in Q2 2026, an estimated $518K.
  • Stoke Therapeutics made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #722 holding.
  • Rafferty Asset Management first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Rafferty Asset Management's Stoke Therapeutics position peaked at $2.86M in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.